Author:
Yeo W.,Boyer M.,Chung H. C.,Ong S. Y. K.,Lim R.,Zee Benny,Ma B.,Lam K. C.,Mo F. K. F.,Ng E. K. W.,Ho R.,Clarke S.,Roh J. K.,Beale P.,Rha S. Y.,Jeung H. C.,Soo R.,Goh B. C.,Chan A. T. C.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference31 articles.
1. Landis SH, Murray T, Bolded S, Wingo PA (1998) Cancer statistics. CA Cancer J Clin 48:6–29
2. Cancer incidence and mortality in Hong Kong 1998–1999. Hong Kong Cancer Registry, Hospital Authority, 2000
3. Pyrhonen S, Kuitunen T, Nyandoto P, Kouri M (1995) Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br J Cancer 71:587–591
4. Glimelius B, Ekstrom K, Hoffman K, Graf W, Sjoden PO, Haglund U, Svenson C, Enander LK, Linne T, Sellstrom H, Heuman R (1997) Randomized comparison between chemotherapy plus supportive care in advanced gastric cancer. Ann Oncol 18:3390–3399
5. Findlay M, Cunningham D, Norman A, Mansi J, Nicolson M, Hickish T, Nicolson V, Nash A, Sacks N, Ford H, et al (1994) A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF). Ann Oncol 5(7):609–616
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献